The Transmitter·2 min read·hard
Using antisense oligos to plumb rare genetic conditions, and more
✦AI Summary
Recent research highlights the use of antisense oligonucleotides (ASOs) to treat rare genetic conditions associated with autism, such as SCN2A variants and Bainbridge-Ropers syndrome. These studies suggest that targeted genetic therapies can improve motor and language skills in children.
Add us as a Preferred Source on Google Set us as a Preferred Source to see The Transmitter more prominently in your Google Search results. Using antisense oligos to plumb rare genetic conditions, and more Here is a roundup of autism-related news and research spotted around the web for the week of 3 August.
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in